Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb;69(2):120-121.
doi: 10.1016/j.redare.2021.02.008. Epub 2022 Feb 7.

Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit

A González-Castro  1 , E Cuenca Fito  2 , A Fernández  2 , P Escudero Acha  2 , J C Rodríguez Borregán  2 , Y Peñasco  2
Affiliations
Comment

Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit

A González-Castro et al. Rev Esp Anestesiol Reanim (Engl Ed). 2022 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival curve (Kaplan–Meier) showing 28-day survival in the study groups. The dashed line shows patients treated with corticosteroid therapy. The solid line shows survival in patients not treated with corticosteroids.
See this image and copyright information in PMC

Comment on

  • Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.
    Villar J, Ferrando C, Martínez D, Ambrós A, Muñoz T, Soler JA, Aguilar G, Alba F, González-Higueras E, Conesa LA, Martín-Rodríguez C, Díaz-Domínguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, Añón JM, Fernández RL, González-Martín JM; dexamethasone in ARDS network. Villar J, et al. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7. Lancet Respir Med. 2020. PMID: 32043986 Clinical Trial.

References

    1. Villar J., Ferrando C., Martínez D., Ambrós A., Muñoz T., Soler J.A., et al. Dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020;8:267–276. doi: 10.1016/S2213-2600(19)30417-5. - DOI - PubMed
    1. The RECOVERY Collaborative Group Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436. - DOI - PMC - PubMed
    1. Lamontagne F., Agoritsas T., Macdonald H. A living WHO guideline on drugs for COVID-19. BMJ. 2020;370:m3379. doi: 10.1136/bmj.m3379. - DOI - PubMed
    1. The WHO Rapid Evidence Appraisal for COVID-19 therapies (REACT) working group Association between systemic corticosteroids administration and mortality among critically ill patients with Covid-19: a meta-analysis. JAMA. 2020;324:1330–1341. doi: 10.1001/jama.2020.17023. - DOI - PMC - PubMed
    1. Zhu L., She Z.G., Cheng X., Qin J.J., Zhang X.J., Cai J., et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31:1068–1077. doi: 10.1016/j.cmet.2020.04.021. - DOI - PMC - PubMed

Substances